Search research articles
Contact Us
Filters
Showing results (81-90 of 174) with videos related to
Page
of 18
Sort By:
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)
|
September 28, 2012
Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation
Joseph N Jarvis, Nelesh Govender, Tom Chiller, et al.
The Journal of Infectious Diseases
|
August 19, 2024
Ex Vivo Host Transcriptomics During Cryptococcus neoformans, Cryptococcus gattii, and Candida albicans Infection of Peripheral Blood Mononuclear Cells From South African Volunteers
Ronan M Doyle, Shichina Kannambath, Alan Pittman, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
July 27, 2011
Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts--time to implement in South Africa?
Joseph N Jarvis, Thomas S Harrison, Nelesh Govender, et al.
BMJ Open
|
April 6, 2021
The Lived Experience Of Participants in an African RandomiseD trial (LEOPARD): protocol for an in-depth qualitative study within a multisite randomised controlled trial for HIV-associated cryptococcal meningitis
David S Lawrence, Katlego Tsholo, Agnes Ssali, et al.
Plos Pathogens
|
May 17, 2011
Low diversity Cryptococcus neoformans variety grubii multilocus sequence types from Thailand are consistent with an ancestral African origin
Sitali P Simwami, Kantarawee Khayhan, Daniel A Henk, et al.
G3 (Bethesda, Md.)
|
February 12, 2017
A Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection
Johanna Rhodes, Mathew A Beale, Mathieu Vanhove, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 5, 2011
Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis
Angela Loyse, Douglas Wilson, Graeme Meintjes, et al.
Molecular Ecology
|
November 19, 2016
Genomic epidemiology of Cryptococcus yeasts identifies adaptation to environmental niches underpinning infection across an African HIV/AIDS cohort
Mathieu Vanhove, Mathew A Beale, Johanna Rhodes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 2, 2022
Association of Antibody Immunity With Cryptococcal Antigenemia and Mortality in a South African Cohort With Advanced Human Immunodeficiency Virus Disease
Hyunah Yoon, Rachel M Wake, Antonio S Nakouzi, et al.
The Journal of Antimicrobial Chemotherapy
|
June 7, 2011
Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice
Ann Sturdy, Anna Goodman, Ricardo J José, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 174) with videos related to
Sort By:
Page
of 18
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)
|
September 28, 2012
Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation
Joseph N Jarvis, Nelesh Govender, Tom Chiller, et al.
The Journal of Infectious Diseases
|
August 19, 2024
Ex Vivo Host Transcriptomics During Cryptococcus neoformans, Cryptococcus gattii, and Candida albicans Infection of Peripheral Blood Mononuclear Cells From South African Volunteers
Ronan M Doyle, Shichina Kannambath, Alan Pittman, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
July 27, 2011
Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts--time to implement in South Africa?
Joseph N Jarvis, Thomas S Harrison, Nelesh Govender, et al.
BMJ Open
|
April 6, 2021
The Lived Experience Of Participants in an African RandomiseD trial (LEOPARD): protocol for an in-depth qualitative study within a multisite randomised controlled trial for HIV-associated cryptococcal meningitis
David S Lawrence, Katlego Tsholo, Agnes Ssali, et al.
Plos Pathogens
|
May 17, 2011
Low diversity Cryptococcus neoformans variety grubii multilocus sequence types from Thailand are consistent with an ancestral African origin
Sitali P Simwami, Kantarawee Khayhan, Daniel A Henk, et al.
G3 (Bethesda, Md.)
|
February 12, 2017
A Population Genomics Approach to Assessing the Genetic Basis of Within-Host Microevolution Underlying Recurrent Cryptococcal Meningitis Infection
Johanna Rhodes, Mathew A Beale, Mathieu Vanhove, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 5, 2011
Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis
Angela Loyse, Douglas Wilson, Graeme Meintjes, et al.
Molecular Ecology
|
November 19, 2016
Genomic epidemiology of Cryptococcus yeasts identifies adaptation to environmental niches underpinning infection across an African HIV/AIDS cohort
Mathieu Vanhove, Mathew A Beale, Johanna Rhodes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 2, 2022
Association of Antibody Immunity With Cryptococcal Antigenemia and Mortality in a South African Cohort With Advanced Human Immunodeficiency Virus Disease
Hyunah Yoon, Rachel M Wake, Antonio S Nakouzi, et al.
The Journal of Antimicrobial Chemotherapy
|
June 7, 2011
Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice
Ann Sturdy, Anna Goodman, Ricardo J José, et al.
Page
of 18